title: Soft-tissue tumors among beagles injected with 226Ra.
abstract: A total of 409 primary soft-tissue tumors (189 malignant) occurred among 87 of 120 young adult beagles (72.5%) injected with 226Ra in eight dose levels ranging from 0.2-440 kBq kg-1 body mass, while a total of 565 primary soft-tissue tumors (208 of them malignant) were seen among 117 of 133 control beagles not given radioactivity (88%). Because the p-value for the difference in these two percentages was > 0.05, further comparisons were not made of all tumor locations or types taken together but only of the individual tumor locations or types. There was a clear excess of malignant tumors and all tumors (benign plus malignant) in the eye among dogs injected with radium (p < 0.05, p < 0.01, respectively), but the occurrence of all the other types of soft-tissue tumors was not greater in irradiated vs. control dogs (p > 0.05). This was also true for hematopoietic tumor types (including just one leukemia in a control and none in irradiated dogs) in which there was no difference between controls and dogs given radium. The following total tumors (benign plus malignant) occurred in control dogs but not in radium dogs: brain = 3, peritoneum = 1, and pituitary = 4. Malignant tumors other than leukemia appearing in control animals and not among radium dogs were brain = 2, lymph nodes = 1, adrenal = 3, uterus = 1, and pancreas = 5. Tumors that occurred in dogs given radium and not in controls were 3 mast cell sarcomas and 2 tumors of the thymus (1 malignant). Age at first tumor diagnosis for corresponding tumor types did not seem to differ (p > 0.10 or p > 0.05) between radium dogs and controls except for the eye (p < 0.05), with radium dogs being somewhat younger than controls at first diagnosis, at death, or at loss from the colony. Cox regression indicated differences between radium dogs and controls in risk of dying with specific tumors. The following tumors had p values of < 0.05 and risk ratios of > 2.2:eye, mouth (mostly melanomas), and thyroid for malignant tumors and for malignant and benign tumors together. When all sarcomas were considered as a group, there was no difference between controls and radium dogs but there was a difference for all carcinomas taken together, even when mammary tumors and eye tumors were excluded and when eye tumors alone were excluded.
authors.affiliation: Radiobiology Division, University of Utah, Salt Lake City 84112.
authors.forename: R D
authors.initials: RD
authors.lastname: Lloyd
authors.forename: G N
authors.initials: GN
authors.lastname: Taylor
authors.forename: W
authors.initials: W
authors.lastname: Angus
authors.forename: F W
authors.initials: FW
authors.lastname: Bruenger
authors.forename: S C
authors.initials: SC
authors.lastname: Miller
mesh_terms: D000818:Animals; D004285:Dogs; D005260:Female; D007275:Injections, Intravenous; D008297:Male; D009381:Neoplasms, Radiation-Induced / Q000209:etiology*; D011883:Radium / Q000008:administration & dosage*; D012983:Soft Tissue Neoplasms / Q000209:etiology*
chemical_list: D011883:Radium